|
Index | - | P/E | - | EPS (ttm) | - | Insider Own | 37.84% | Shs Outstand | 10.95M | Perf Week | 1.59% |
Market Cap | 63.89M | Forward P/E | - | EPS next Y | -0.58 | Insider Trans | 0.00% | Shs Float | 1.33M | Perf Month | -6.21% |
Income | - | PEG | - | EPS next Q | -0.16 | Inst Own | 0.63% | Short Float | 0.72% | Perf Quarter | 63.07% |
Sales | - | P/S | - | EPS this Y | -140.30% | Inst Trans | - | Short Ratio | 0.01 | Perf Half Y | -0.17% |
Book/sh | 0.34 | P/B | 16.88 | EPS next Y | 41.40% | ROA | - | Target Price | - | Perf Year | - |
Cash/sh | 0.13 | P/C | 42.59 | EPS next 5Y | - | ROE | - | 52W Range | 3.15 - 12.18 | Perf YTD | 8.30% |
Dividend | - | P/FCF | - | EPS past 5Y | - | ROI | -392.20% | 52W High | -52.87% | Beta | - |
Dividend % | - | Quick Ratio | 0.90 | Sales past 5Y | - | Gross Margin | - | 52W Low | 82.22% | ATR | 0.44 |
Employees | 101 | Current Ratio | 0.90 | Sales Q/Q | -37.90% | Oper. Margin | - | RSI (14) | 55.95 | Volatility | 4.42% 6.11% |
Optionable | No | Debt/Eq | 0.24 | EPS Q/Q | -83.20% | Profit Margin | - | Rel Volume | 0.02 | Prev Close | 5.71 |
Shortable | Yes | LT Debt/Eq | 0.00 | Earnings | - | Payout | - | Avg Volume | 1.59M | Price | 5.74 |
Recom | 2.00 | SMA20 | 2.10% | SMA50 | 17.97% | SMA200 | -1.01% | Volume | 24,725 | Change | 0.53% |
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anpac Bio-Medical Science Co., Ltd., a development-stage biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China and the United States. It also manufactures cancer differentiation analysis devices; and offers physical checkup package services. The company was founded in 2010 and is headquartered in Lishui, the People's Republic of China. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
open in yahoo | open in reuters | open in google |
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite